Information Journal Paper
APA:
Copy. (2020). Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of pglycoprotein and inhibition of ROS-mediated TNF-α /NF-κ B pathways. DRUG CHEM TOXICOL, 27(-), 1-12. SID. https://sid.ir/paper/697794/en
Vancouver:
Copy. Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of pglycoprotein and inhibition of ROS-mediated TNF-α /NF-κ B pathways. DRUG CHEM TOXICOL[Internet]. 2020;27(-):1-12. Available from: https://sid.ir/paper/697794/en
IEEE:
Copy, “Montelukast ameliorates doxorubicin-induced cardiotoxicity via modulation of pglycoprotein and inhibition of ROS-mediated TNF-α /NF-κ B pathways,” DRUG CHEM TOXICOL, vol. 27, no. -, pp. 1–12, 2020, [Online]. Available: https://sid.ir/paper/697794/en